mail2

Spectrum Library

Rituximab in Neuromyelitis Optica Spectrum Disorders-Reply: Why Not as First-Line Therapy.

JAMA Neurol. 2017 Apr 1;74(4):482-483. doi: 10.1001/jamaneurol.2016.5936.

Damato V1, Evoli A1, Iorio R2.

Join the Discussion

PLEASE HELP – I AM HAVING DIFFICULTY ACCESSING THIS ARTICLE.
Rituximab in Neuromyelitis Optica Spectrum Disorders-Reply: Why Not as First-Line Therapy.

Hi Sandra,

This post has been updated to include the link to the scientific article.

Leave a Comment

Share
Tweet
Share
+1
0 Shares